{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:06:59Z","timestamp":1790096819415,"version":"4.0.1"},"reference-count":45,"publisher":"Impact Journals, LLC","issue":"38","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,12,1]]},"DOI":"10.18632\/oncotarget.5723","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T10:20:53Z","timestamp":1446027653000},"page":"40907-40919","source":"Crossref","is-referenced-by-count":87,"title":["Disulfiram inhibits TGF-\u03b2-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK\/NF-\u03baB\/Snail pathway"],"prefix":"10.18632","volume":"6","author":[{"given":"Dan","family":"Han","sequence":"first","affiliation":[{"name":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[{"name":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Chang","sequence":"additional","affiliation":[{"name":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Xiao","sequence":"additional","affiliation":[{"name":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhui","family":"Li","sequence":"additional","affiliation":[{"name":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,16]]},"reference":[{"key":"1","article-title":"Global cancer statistics, 2012","author":"Jemal","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/annonc\/mdu385","article-title":"ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)dagger","volume":"25","author":"Francis","year":"2014","journal-title":"Ann Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ceb.2003.10.006","article-title":"Epithelial-mesenchymal transitions in development and pathologies","volume":"15","author":"Thiery","year":"2003","journal-title":"Curr Opin Cell Biol"},{"key":"4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Nieto","year":"2009","journal-title":"Cell"},{"key":"5","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1158\/0008-5472.CAN-09-1618","article-title":"Epithelial-mesenchymal transition and cell cooperativity in metastasis","volume":"69","author":"Hu","year":"2009","journal-title":"Cancer Res"},{"key":"6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","article-title":"Epithelial-mesenchymal transition in cancer development and its clinical significance","volume":"101","author":"Mori","year":"2010","journal-title":"Cancer Sci"},{"key":"7","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.2174\/138920111798377102","article-title":"Epithelial-mesenchymal transition: implications in cancer progression and metastasis","volume":"12","author":"Labriola","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12282-011-0321-2","article-title":"The roles of TGF-beta signaling in carcinogenesis and breast cancer metastasis","volume":"19","author":"Inoue","year":"2012","journal-title":"Breast Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/onc.2009.399","article-title":"Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies","volume":"29","author":"O'Connor-McCourt","year":"2010","journal-title":"Oncogene"},{"key":"10","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4161\/cc.9.8.11517","article-title":"Role of beta5-integrin in epithelial-mesenchymal transition in response to TGF-beta","volume":"9","author":"Bakin","year":"2010","journal-title":"Cell Cycle"},{"key":"11","doi-asserted-by":"crossref","first-page":"19035","DOI":"10.1073\/pnas.0910009106","article-title":"p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression","volume":"106","author":"Pestell","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12","first-page":"1171","article-title":"IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures","volume":"40","author":"Yuan","year":"2012","journal-title":"Int J Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Weinberg","year":"2008","journal-title":"Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3892\/ijo.2013.2225","article-title":"Snail-induced epithelial-mesenchymal transition promotes cancer stem cell-like phenotype in head and neck cancer cells","volume":"44","author":"Hosoi","year":"2014","journal-title":"Int J Oncol"},{"key":"15","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.4161\/cbt.6.11.5167","article-title":"Cancer stem cell and cancer stemloids: from biology to therapy","volume":"6","author":"Blagosklonny","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"16","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ejca.2010.02.030","article-title":"Cancer stemness and metastasis: therapeutic consequences and perspectives","volume":"46","author":"Fodde","year":"2010","journal-title":"Eur J Cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Clarke","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18","first-page":"R7","article-title":"CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial\/basal and non-epithelial cells","volume":"8","author":"Smalley","year":"2006","journal-title":"Breast Cancer Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Dontu","year":"2007","journal-title":"Cell Stem Cell"},{"key":"20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488808786734006","article-title":"Aldehyde dehydrogenase as a marker for stem cells","volume":"3","author":"Moreb","year":"2008","journal-title":"Curr Stem Cell Res Ther"},{"key":"21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200421358","article-title":"NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression","volume":"114","author":"Wirth","year":"2004","journal-title":"J Clin Invest"},{"key":"22","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.4161\/cc.3.12.1280","article-title":"Epithelial-mesenchymal transition: NF-kappaB takes center stage","volume":"3","author":"Wirth","year":"2004","journal-title":"Cell Cycle"},{"key":"23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/bcr2886","article-title":"NF-kappaB, stem cells and breast cancer: the links get stronger","volume":"13","author":"Chariot","year":"2011","journal-title":"Breast cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1242\/dmm.001321","article-title":"Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK\/NF-kappaB\/Snail1 pathway","volume":"1","author":"del Pozo","year":"2008","journal-title":"Dis Model Mech"},{"key":"25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ijc.10972","article-title":"Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines","volume":"104","author":"Cassidy","year":"2003","journal-title":"Int J Cancer"},{"key":"26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/156800911794519806","article-title":"Targeting malignancies with disulfiram (Antabuse): multidrug resistance, angiogenesis, and proteasome","volume":"11","author":"Cvek","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"27","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/ijc.21534","article-title":"Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram","volume":"118","author":"Larsson","year":"2006","journal-title":"Int J Cancer"},{"key":"28","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1038\/onc.2009.214","article-title":"Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction","volume":"28","author":"Bonavida","year":"2009","journal-title":"Oncogene"},{"key":"29","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/bjc.2012.442","article-title":"Cytotoxic effect of disulfiram\/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells","volume":"107","author":"Wang","year":"2012","journal-title":"Br J Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.18632\/oncotarget.604","article-title":"Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide","volume":"3","author":"Dunn","year":"2012","journal-title":"Oncotarget"},{"key":"31","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.18632\/oncotarget.707","article-title":"High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells","volume":"3","author":"Foltz","year":"2012","journal-title":"Oncotarget"},{"key":"32","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bjc.2011.126","article-title":"Disulfiram modulated ROS-MAPK and NFkappaB pathways and targeted breast cancer cells with cancer stem cell-like properties","volume":"104","author":"Wang","year":"2011","journal-title":"Br J Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/bjc.2013.534","article-title":"Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells","volume":"109","author":"Wang","year":"2013","journal-title":"Br J Cancer"},{"key":"34","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.18632\/oncotarget.2166","article-title":"Liposome encapsulated Disulfiram inhibits NFkappaB pathway and targets breast cancer stem cellsand","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1593\/neo.04241","article-title":"Activation of the Erk pathway is required for TGF-beta1-induced EMT","volume":"6","author":"Moses","year":"2004","journal-title":"Neoplasia"},{"key":"36","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1038\/sj.onc.1207990","article-title":"Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells","volume":"23","author":"Garcia de Herreros","year":"2004","journal-title":"Oncogene"},{"key":"37","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ncb1905","article-title":"A SNAIL1-SMAD3\/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition","volume":"11","author":"Fuxe","year":"2009","journal-title":"Nat Cell Biol"},{"key":"38","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/15680096113136660102","article-title":"The Role of Snail in EMT and Tumorigenesis","volume":"13","author":"Zhou","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/bcr2876","article-title":"Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition","volume":"13","author":"Ivy","year":"2011","journal-title":"Breast Cancer Res"},{"key":"40","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.18632\/oncotarget.2957","article-title":"FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells","volume":"6","author":"Chou","year":"2014","journal-title":"Oncotarget"},{"key":"41","first-page":"716","article-title":"The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor?","volume":"13","author":"Dvorak","year":"2008","journal-title":"Drug Discov Today"},{"key":"42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.taap.2008.01.022","article-title":"Disulfiram promotes the conversion of carcinogenic cadmium to a proteasome inhibitor with pro-apoptotic activity in human cancer cells","volume":"229","author":"Dou","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canlet.2009.09.002","article-title":"Disulfiram\/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines","volume":"290","author":"Wang","year":"2010","journal-title":"Cancer Lett"},{"key":"44","first-page":"197","article-title":"Disulfiram induces apoptosis in human melanoma cells: a redox-related process","volume":"1","author":"Meyskens","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/stem.563","article-title":"Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis","volume":"29","author":"Lee","year":"2011","journal-title":"Stem Cells"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5723","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T09:21:44Z","timestamp":1599729704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,16]]},"references-count":45,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2015,12,1]]}},"alternative-id":["5723","26517513"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5723","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,16]]}}}